Validation of the decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the sakk 09/10 randomized clinical trial☆

HIGHLIGHTS

• who: A. Dal Pra from the Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, USA have published the Article: Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial☆, in the Journal: (JOURNAL)

SUMMARY

More than 40% of intermediate- or high-risk prostate cancers are estimated to recur after radical prostatectomy, which suggests more than 30 000 men every year in the United_States are diagnosed with biochemically recurrent disease. Conventional clinicopathologic . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.